Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Fig. 3

Characterization and quantification of circulating MVs by flow cytometery in plasma from patient groups DLP (n = 14), T2D (n = 17), T2D-DLP (n = 17) and group C (n = 15) of healthy subjects. Representative dot-plots assigned for MV quantification, based on calibration beads of 10 μm in diameter and 1000/µL concentration (A), and MV purity based on the percentages of MVs positive for Annexin V (B). Annexin-V-positive plasma MV concentrations for all groups of subjects investigated (C). Data are represented as means ± SD. &p < 0.05, &&p < 0.01 (vs C) (One-Way ANOVA with Bonferroni’s Multiple Comparison Test)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840